Please login to the form below

Not currently logged in
Email:
Password:

Estonia

This page shows the latest Estonia news and features for those working in and with pharma, biotech and healthcare.

Value for money healthcare - Macedonia and Estonia lead

Value for money healthcare - Macedonia and Estonia lead

Value for money healthcare - Macedonia and Estonia lead. Latest EHCI report praises the countries' ‘ imaginative and determined’ approach to healthcare access. ... Estonia and the Czech Republic provide very good healthcare in relation to the cost,

Latest news

  • Lilly and Boehringer launch Lantus biosimilar in UK Lilly and Boehringer launch Lantus biosimilar in UK

    Lilly and Boehringer's biosimilar was approved in Europe last September and introduced in some Eastern Europe markets earlier this year - including the Czech Republic, Slovakia and Estonia where pricing has

  • Sanofi keeps Toujeo price level with Lantus in UK Sanofi keeps Toujeo price level with Lantus in UK

    Biosimilar Lantus is now available in the Czech Republic, Slovakia and Estonia where it has been launched at a discount of 15%-20% of the brand's price, according to

  • NICE backs drug to cut alcohol consumption NICE backs drug to cut alcohol consumption

    Lundbeck has already launched Selincro in Northern Europe in countries such as Norway, Finland, Poland, Latvia, Lithuania and Estonia and the company is likely to ramp up marketing in England now

  • NICE recommends Lundbeck’s alcohol dependency drug NICE recommends Lundbeck’s alcohol dependency drug

    Selincro has already been launched in Northern Europe in countries such as Norway, Finland, Poland, Latvia, Lithuania and Estonia and Lundbeck is likely to ramp up marketing in England once final

  • Tuberculosis: treatment and prevention Tuberculosis: treatment and prevention

    adults. Phase 2 clinical studies of the vaccine candidate have been completed in Switzerland, Belgium, Gambia, South Africa and the Philippines, and are ongoing in Taiwan, India and Estonia. ... Delamanid is also in phase 3 development in the US, Estonia,

More from news
Approximately 2 fully matching, plus 29 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
CACTUS

Founded in 2002, Cactus Communications is a fully integrated, global scholarly communications company with offices in Japan, South Korea, India,...

Latest intelligence

No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...

Infographics